19 completed, 9 terminated, 1 unknown. 15 Phase 2, 8 Phase 1, 6 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 15 | Completed 9, Terminated 6 |
| Phase 1 | 8 | Completed 6, Terminated 2 |
| Not applicable | 6 | Completed 4, Terminated 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Stage IV Bladder Cancer: new trials by email Literature Review of Stage IV Bladder Cancer trials Research Report on Stage IV Bladder Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ask Questions (ASQ):Implementation of a Communication Intervention Behavioral Intervention - Stage II Breast Cancer, Stage III Breast Cancer | Not applicable | Completed | Barbara Ann Karmanos Cancer Institute | 81 | 2021-08-25 | 2023-08-16 |
| Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer Educational Video and QPL List, Usual Care - Stage IV Melanoma, Advanced Lung Cancer | Not applicable | Completed | Massachusetts General Hospital | 199 | 2021-01-23 | 2026-08-25 |
| Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites Canady Helios Cold Plasma Scalpel - Recurrent Malignant Solid Neoplasm, Stage IV Breast Cancer | Not applicable | Unknown | Jerome Canady, M.D. | 20 | 2019-07-30 | 2021-08-09 |
| Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma Enzyme Inhibitor Therapy, Laboratory Biomarker Analysis, Nivolumab - Lymphoma, Metastatic Malignant Solid Neoplasm | Phase 1 | Completed | Rutgers, The State University of New Jersey | 14 | 2017-10-03 | 2023-12-06 |
| Afatinib in Advanced Refractory Urothelial Cancer afatinib dimaleate, laboratory biomarker analysis - Distal Urethral Cancer, Proximal Urethral Cancer | Phase 2 | Terminated | University of Chicago | 32 | 2017-09-13 | 2025-04-25 |
| Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer Best Practice, Laboratory Biomarker Analysis, Supportive Care - Acute Myeloid Leukemia, Brain Glioblastoma | Not applicable | Completed | Stanford University | 128 | 2017-08-08 | 2025-01-24 |
| Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer Intensity-Modulated Radiation Therapy - Stage III Bladder Cancer, Stage IV Bladder Cancer | Phase 2 | Terminated | NRG Oncology | 14 | 2015-02-01 | 2026-05-22 |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers educational intervention, telephone-based intervention, quality-of-life assessment - Healthy Subject, Localized Transitional Cell Cancer of the Renal Pelvis and Ureter | Not applicable | Completed | City of Hope Medical Center | 200 | 2013-10-29 | 2026-10-01 |
| Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer Cisplatin, Gemcitabine Hydrochloride, Sirolimus - Recurrent Bladder Carcinoma, Stage II Bladder Cancer | Phase 1 / Phase 2 | Completed | University of Washington | 21 | 2013-10-01 | 2017-10-20 |
| Adjuvant Radiation for High Risk Bladder Cancer 3D conformal radiation therapy - Bladder Cancer, Squamous Cell Carcinoma of the Bladder | Not applicable | Terminated | Emory University | 19 | 2013-07-22 | 2022-03-02 |
| Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder docetaxel, lapatinib ditosylate, immunohistochemistry staining method - Recurrent Bladder Cancer, Stage III Bladder Cancer | Phase 2 | Terminated | University of Southern California | 15 | 2011-06-13 | 2025-10-09 |
| Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer gemcitabine hydrochloride, veliparib, diagnostic laboratory biomarker analysis - Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer | Phase 1 | Terminated | National Cancer Institute (NCI) | 44 | 2011-01-01 | 2013-07-02 |
| Pazopanib in Treating Patients With Metastatic Urothelial Cancer pazopanib hydrochloride - Distal Urethral Cancer, Proximal Urethral Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 19 | 2008-08-01 | 2014-05-30 |
| Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function Gemcitabine hydrochloride, Paclitaxel, Doxorubicin hydrochloride - Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Completed | M.D. Anderson Cancer Center | 40 | 2007-04-01 | 2020-10-09 |
| VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium ziv-aflibercept, pharmacological study - Adenocarcinoma of the Bladder, Distal Urethral Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 22 | 2006-11-01 | 2014-10-20 |
| Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium sorafenib tosylate, laboratory biomarker analysis - Adenocarcinoma of the Bladder, Distal Urethral Cancer | Phase 2 | Terminated | National Cancer Institute (NCI) | 27 | 2005-10-01 | 2014-05-30 |
| Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract sorafenib tosylate, laboratory biomarker analysis - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 17 | 2005-04-01 | 2018-07-27 |
| Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma Trastuzumab, Gemcitabine, Carboplatin - Recurrent Bladder Cancer, Stage IV Bladder Cancer | Phase 2 | Completed | Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | 61 | 2004-02-09 | 2017-02-06 |
| Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma bortezomib - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Bladder Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 40 | 2003-10-01 | 2013-06-05 |
| Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy Recombinant Fowlpox-TRICOM Vaccine, Recombinant Fowlpox GM-CSF Vaccine Adjuvant, Therapeutic Conventional Surgery - Bladder Adenocarcinoma, Bladder Squamous Cell Carcinoma | Phase 1 | Terminated | National Cancer Institute (NCI) | 21 | 2003-10-01 | 2014-12-23 |
Showing 20 of 29. Sign in to see all of them.
Urinary Bladder Neoplasms (29) · Urethral Neoplasms (10) · Breast Neoplasms (7) · Carcinoma, Non-Small-Cell Lung (7) · Carcinoma, Renal Cell (6) · Pancreatic Neoplasms (6) · Colonic Neoplasms (5) · Rectal Neoplasms (5) · Stomach Neoplasms (5) · Uterine Cervical Neoplasms (5) · Esophageal Neoplasms (4) · Melanoma (4) · Prostatic Neoplasms (4) · Squamous Cell Carcinoma of Head and Neck (4) · Breast Neoplasms, Male (3)
Female Urogenital Diseases (29) · Female Urogenital Diseases and Pregnancy Complications (29) · Male Urogenital Diseases (29) · Neoplasms (29) · Neoplasms by Site (29) · Urinary Bladder Diseases (29) · Urogenital Diseases (29) · Urogenital Neoplasms (29) · Urologic Diseases (29) · Urologic Neoplasms (29) · Urethral Diseases (10) · Lung Diseases (9) · Neoplasms by Histologic Type (9) · Respiratory Tract Diseases (9) · Respiratory Tract Neoplasms (9)
Gemcitabine (6) · Cisplatin (4) · Trastuzumab (4) · Carboplatin (2) · Doxorubicin (2) · Paclitaxel (2) · Radiotherapy, Intensity-Modulated (2) · Sorafenib (2) · Taxes (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Afatinib (1) · Behavior Therapy (1) · Bortezomib (1) · Cystectomy (1) · Decitabine (1)
National Cancer Institute (NCI) (14) · Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie (1) · Barbara Ann Karmanos Cancer Institute (1) · Burzynski Research Institute (1) · City of Hope Medical Center (1) · Emory University (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Jerome Canady, M.D. (1) · M.D. Anderson Cancer Center (1) · Massachusetts General Hospital (1) · NRG Oncology (1) · Rutgers, The State University of New Jersey (1) · Stanford University (1) · University of Chicago (1) · University of Southern California (1)
United States (26) · Canada (2) · Belgium (1) · China (1) · France (1) · Israel (1) · South Korea (1)
Robert Dreicer (2) · Antonius Miller (1) · Arif Hussain (1) · Betty Ferrell (1) · Biren Saraiya (1) · Cora Sternberg, Dr. (1) · David Quinn, M.D. (1) · Jeffrey Weber (1) · Jonathan Rosenberg (1) · Joseph W Shelton, MD (1) · Lance Pagliaro (1) · Lance Pagliaro, MD, BA (1) · Laura A Petrillo, MD (1) · Leonard Appleman (1) · Libni Eapen (1)
PMID 25459391, PMID 25498218, PMID 34749008, PMID 35771552, PMID 35780243, PMID 37509349, PMID 39462179, PMID 39938469
U10CA031946 (3), P30CA072720 (2), U10CA021115 (2), 2005 (1), N01CM17101 (1), N01CM62201 (1), N01CM62203 (1), N01CM62205 (1), N01CM62209 (1), N02CM62212 (1), P30CA014599 (1), P30CA015704 (1), R21CA076233 (1), U01CA062487 (1), U01CA062505 (1)